Table 1 Patient clinical characteristics by sex at the time of adipose tissue assessment

Age (years)

54.70 ± 10.77

51.19 ± 10.37

59.8 ± 9.21

< 0.001

Etiologic cause, n (%)

Hepatitis B

140(49.6%)

101(60.5%)

39(33.9%)

< 0.001

Hepatitis C

12(4.3%)

6(3.6%)

6(5.2%)

0.716

Alcohol

28(9.9%)

28(16.8%)

0

< 0.001

Autoimmune

27(9.6%)

6(3.6%)

21(18.3%)

< 0.001

Others

75(26.6%)

26(15.6%)

49(42.6%)

< 0.001

Laboratory date

Hemoglobin (g/L)

85.29 ± 14.79

84.60 ± 14.33

86.28 ± 15.43

0.351

Platelet count (10⁹/L)

83.92 ± 55.03

78.19 ± 41.93

92.24 ± 69.19

0.035

creatinine (µmol/L)

65.35 ± 14.74

71.74 ± 13.77

56.07 ± 10.63

< 0.001

Total bilirubin (µmol/L)

19.19 ± 11.77

20.37 ± 12.68

17.48 ± 10.13

0.043

ALT (U/L)

26.70 ± 20.53

28.44 ± 21.78

24.16 ± 18.37

0.085

AST (U/L)

31.57 ± 17.84

32.20 ± 20.17

30.65 ± 13.81

0.474

Serum albumin (g/L)

36.13 ± 4.74

36.31 ± 4.72

35.88 ± 4.78

0.463

PT (s)

14.82 ± 1.98

15.25 ± 1.96

14.19 ± 1.84

< 0.001

INR

1.31 ± 0.18

1.36 ± 0.18

1.24 ± 0.16

< 0.001

D-dimer (g/L)

1.04 ± 1.26

1.09 ± 1.32

0.96 ± 1.15

0.396

Child-Pugh score

6.57 ± 1.49

6.71 ± 1.58

6.36 ± 1.35

0.050

MELD score

10.09 ± 2.39

10.60 ± 2.50

9.35 ± 1.99

< 0.001

Number of endoscopic treatments

2.62 ± 0.89

2.61 ± 0.88

2.63 ± 0.89

0.887

Number of bands

9.26 ± 3.09

9.79 ± 2.96

8.49 ± 3.11

< 0.001

PVT, n (%)

92(32.6%)

55(32.9%)

37(32.2%)

0.894

Ascites, n (%)

137(48.6%)

81(48.5%)

56(48.7%)

0.975

Diabetes mellitus, n (%)

61(21.6%)

38(22.8%)

23(20.0%)

0.581

NSBBs used

170(60.3%)

99(59.3%)

71(61.7%)

0.679

Body Composition

BMI (kg/m²)

23.65 ± 3.09

24.01 ± 3.02

23.13 ± 3.13

0.019

SATI (cm/m²)

43.75 ± 24.83

36.85 ± 22.22

53.77 ± 25.08

< 0.001

VATI (cm/m²)

37.41 ± 20.69

37.24 ± 22.77

37.64 ± 17.31

0.867

TATI (cm/m²)

81.33 ± 41.17

74.39 ± 41.29

91.41 ± 39.01

0.001